TRICARE Uniform Formulary. Pre-Authorization Requirements

Size: px
Start display at page:

Download "TRICARE Uniform Formulary. Pre-Authorization Requirements"

Transcription

1 TRICARE Uniform Formulary Pre-Authorization Requirements The Department of Defense (DoD) requires pre-authorization on select medications. These medications are on the DoD s pre-authorization list because of high cost or because the drugs are conditionally eligible. This list is not all-inclusive and is subject to change. Refer to the DoD Pharmacoeconomic Center ( for the most current listing of prescription drugs that are subject to pre-authorization requirements. Maxor Plus Pharmacy is also able to assist with TRICARE Uniform Formulary questions. Contact Maxor Plus Pharmacy at (phone) or (fax). Comments Classification Name Generic Name Aciphex Rabeprrazole Actoplus Met/Actoplus Met XR Pioglitazone Hydrocloride Actos Pioglitazone Hydrochloride Adcirca Tadalfil Advicor Lovastatin; Niacin Altoprev Lovastatin Ambien CR Zolpidem extended release Amevive Amturnide Atacand Avalide Alefacept Amolodipine Besylate; Hydrochlorothiazide Candesartan Cilexetil Hydroclorothiazide: Irbesartan

2 Avandamet Avandaryl Avandia Avapro Avinza Azor Benicar/Benicar HCT Bravelle Byetta Rosiglitazone Maleate Glimepiride: Rosiglitazone Maleate Rosiglitazone Irbesartan Morphine Sulfate Hydrochlorothiazide; Urofollitropin Exenatide High potency opioid Caduet Atorvastatin Calcium Cialis Tadalafil ; gender and age restrictions Cimzia Certolizumab Pegol Crestor Rosuvastatin Calcium Dexilant Dexlansoprazole Duetact Glimepiride; Pioglitazone Hydrochloride Duragesic Fentanyl High potency opioid Edarbi Azilsartan Medoxomil Edlur Zolpidem Tartrate Enbrel Etanercept Exalgo Hydromorphone High potency opioid

3 Hydrochloride Fentanyl Fentanyl High potency opioid Follistim AQ Follitropin Beta Genotropin Somatropin Gilenya Fingolimod Hydrochloride Gonal-F/Gonal RFF Follitropin Alfa Humatrope Somatropin Humira Adalimumab Increlex Mecasermin Jalyn Janumet Dutasteride; Tamsulosin Hydrochloride Sitagliptin Phosphate Januvia Sitagliptin Phosphate Kadian Morphine Sulfate High potency opioid Kineret Anakinra Kombiglyze XR Lansoprazole/Lansoprazole ODT Saxagliptin Hydrochloride Lansoprazole Lescol/Lescol XL Fluvastatin Sodium Levitra Vardenafil ; age and gender restrictions Livalo Pitavastatin Calcium Lunesta Eszopiclone Menopur Menotripins Morphine Sulfate ER Morphine Sulfate High potency opioid MS Contin Morphine sulfate High potency opioid

4 Norditropin Flexpro Somatropin Nutropin/Nutropin AQ/Nutropin AQ Nuspin Somatropin Nuvigil Armodafinil Omeprazole/Sodium Bicarbonate Omeprazole; Sodium Bicarbonate Omnitrope Somatropin Onglyza Saxagliptin Hydrochloride Onsolis Fentanyl Citrate High potency opioid Oramorph SR Morphine Sulfate High potency opioid Oxycontin Oxycodone Hydrochloride High potency opioid Pantoprazole Sodium Prevacid/Prevacid 24 hours/prevacid Solutab Pantoprazole Sodium Sesquihydrate Lansoprazole Protonix Pantoprazole Provigil Modanfinil Qualaquin Quinine Sulfate Rapaflo Silodosin Repronex Menotropins Revatio Sildenafil Rozerem Ramelteon Saizen/Saizen Click.Easy Somatropin (Serono) Serostim Somatropin (Serono) Silenor Doxepin Hydrochloride Simcor Niacin; Simvastatin

5 Simponi Golimumab Sonata Zaleplon Symlin Pramlintide Acetate Tekamlo Amlodipine Besylate Tekturna/Tekturna HCT Aliskiren Fumarate Teveten/Teveten HCT Eprosartan Mesylate Tev-Tropin Somatropin Tribenzor Valturna Hydrochlorothiazide; Valsartan Viagra Sildenafil ; age and gender restrictions Victoza Liraglutide Vytorin Ezetimibe; Simvastatin Zaleplon Zaleplon Zegerid Omeprazole/sodium bicardonate Zolpidem Tartrate ER Zolpidem Tartrate Zolphimist Zolpidem Tartrate Zorbtive Somatropin

Generics. Lead with. Prescription Step Therapy Program

Generics. Lead with. Prescription Step Therapy Program Lead with Generics Prescription Step Therapy Program WWW.BCBSLA.COM 04HQ3972 R11/10 Blue Cross and Blue Shield of Louisiana incorporated as Louisiana Health Service & Indemnity Company GENERIC DRUGS: A

More information

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 Promoting high quality, cost effective drug therapy throughout the Military Health System UF Decisions, May 07 Class FY05 rank, total $

More information

ANGIOTENSIN RECEPTOR BLOCKERS

ANGIOTENSIN RECEPTOR BLOCKERS Step Therapy 2014 2 Tier-Alameda Last Updated: 10/10/2014 ANGIOTENSIN RECEPTOR BLOCKERS Benicar Benicar Hct Diovan Valsartan Step 1: First line therapy should be irbesartan, irbesartan/hctz, losartan,

More information

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 6 Jan 2011

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 6 Jan 2011 Beneficiary Advisory Panel Handout Uniform Formulary Decisions 6 Jan 2011 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical effectiveness

More information

STEP THERAPY ALGORITHMS PUP Select Formulary

STEP THERAPY ALGORITHMS PUP Select Formulary The Step Therapy drug will be dispensed if the drug has been dispensed within 120 days of current fill or if alternative (Step 1) drugs have been used first. If the member s prescription claim fails the

More information

Prior Authorization Program

Prior Authorization Program Prescription Drug List January 2011 Prior Authorization Program The prior authorization program helps us offer broad prescription drug coverage and promotes safe, clinically appropriate drug usage. Under

More information

2013 Step Therapy (ST) Criteria

2013 Step Therapy (ST) Criteria 2013 Step Therapy (ST) Criteria Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a

More information

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 24 June 2010

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 24 June 2010 Beneficiary Advisory Panel Handout Uniform Formulary Decisions 24 June 2010 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical

More information

Generics. Lead with. P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m

Generics. Lead with. P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m Lead with Generics P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m WWW.BCBSLA.COM 04HQ3972 5/09 Blue Cross and Blue Shield of Louisiana incorporated as Louisiana Health Service & Indemnity

More information

ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA

ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA Quantity Limits Paramount Medicare Formulary 2012 Formulary ID 12112, Version 22. CMS Approved 10-23-2012. ABILIFY Abilify TABS ABILIFY DISCMELT Abilify Discmelt ACTONEL Actonel TABS 150MG Actonel TABS

More information

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011 Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 211 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical effectiveness

More information

ATYPICAL ANTIPSYCHOTICS

ATYPICAL ANTIPSYCHOTICS Step Therapy CareOregon 2018 Last Updated: 07/27/2018 ATYPICAL ANTIPSYCHOTICS Fanapt Fanapt Titration Pack Paliperidone Er Vraylar The following criteria applies to members who newly start on the drug:

More information

RxBlue 2010 ST Criteria

RxBlue 2010 ST Criteria RxBlue 2010 ST Criteria ANTIDEPRESSANTS - SARAFEM... 10 FLUOXETINE HCL... 10 SARAFEM... 10 SELFEMRA... 10 ANTIDEPRESSANTS- SSRI, SNRI... 11 CELEXA... 11 CITALOPRAM... 11 CYMBALTA... 11 EFFEXOR XR... 11

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end

More information

Step Therapy Criteria

Step Therapy Criteria ADCIRCA ADCIRCA Coverage will be provided if the member has filled a prescription for sildenafil (at least a 30 day supply within the past 365 ) ELIDEL 76-F ELIDEL Coverage will be provided if the member

More information

Connecticut Medicaid P&T Meeting Minutes June 4, 2009

Connecticut Medicaid P&T Meeting Minutes June 4, 2009 Connecticut Medicaid P&T Meeting Minutes June 4, 2009 The meeting started at 6:30 pm Attendance Present Members: Carl Sherter, MD Eric Einstein, MD Lester Silberman, MD Charles Thompson, MD Peggy Manning

More information

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina 29202-8206 Pharmacy and Therapeutics (P&T) Committee Meeting MINUTES 1. Call to Order A meeting of the

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end

More information

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate

More information

Cerner Bulletin Providers Issued: October 2, 2014

Cerner Bulletin Providers Issued: October 2, 2014 Alert Warfarin Ordered without INR CPOE, Nursing and Pharmacy 10/13/14 S B A R Prescribers currently do NOT get a warning if warfarin is actively ordered and there has not been an INR result in the past

More information

II. UF CLASS REVIEWS SHORT-ACTING BETA AGONISTS (SABAs)

II. UF CLASS REVIEWS SHORT-ACTING BETA AGONISTS (SABAs) DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code

More information

Prescription Drug Benefit Rider

Prescription Drug Benefit Rider Prescription Drug Benefit Rider Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your

More information

Three-Tier Prescription Drug Benefits Rider

Three-Tier Prescription Drug Benefits Rider Three-Tier Prescription Drug Benefits Rider Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

Three-Tier Prescription Drug Benefit Rider A

Three-Tier Prescription Drug Benefit Rider A Three-Tier Prescription Drug Benefit Rider A Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions

More information

ADHD STIMULANTS-S(SHC)

ADHD STIMULANTS-S(SHC) Step Therapy Simply Health Care 2014 Formulary ID: 14406 Version: 14 Last Updated: 08/01/2014 ADHD STIMULANTS-S(SHC) Daytrana Focalin Xr Strattera Patient needs to have a paid claim for one Step 1 drug

More information

Step Therapy Program Precision Formulary

Step Therapy Program Precision Formulary Step Therapy Program Precision Formulary Physician Guidelines Failure of previous steps in the Step Therapy Program: For most therapies, Magellan Rx Management will review the most recent 180 days of claim

More information

Oregon Health Plan prescription benefit updates

Oregon Health Plan prescription benefit updates Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save

More information

SELF-ADMINISTERED MEDICATIONS LIST

SELF-ADMINISTERED MEDICATIONS LIST SELF-ADMINISTERED MEDICATIONS LIST Table of Contents Page Last Updated: January 23, 2019 INSTRUCTIONS FOR USE... 1 APPLICABLE CODES... 1 Related Commercial Policy LIST HISTORY/REVISION INFORMATION... 5

More information

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time

More information

Connecticut Medicaid P&T Meeting Minutes June 5, 2008

Connecticut Medicaid P&T Meeting Minutes June 5, 2008 Connecticut Medicaid P&T Meeting Minutes June 5, 2008 The meeting started at 6:30 pm Attendance Present Members: Carl Sherter, MD Kenneth Marcus, MD Lester Silberman, MD Peggy Manning Memoli, Pharm D Richard

More information

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or Noridian Healthcare Solutions, LLC Jurisdiction F Part B Self-Administered Drug (SAD) Exclusion List (A53033); Effective 8/7/2017 The following medications are considered self-administered and are not

More information

STATE OF NEW YORK DEPARTMENT OF HEALTH

STATE OF NEW YORK DEPARTMENT OF HEALTH STATE OF NEW YORK DEPARTMENT OF HEALTH Corning Tower The Governor Nelson A. Rockefeller Empire State Plaza Albany, New York 12237 Antonia C. Novello, M.D., M.P.H., Dr.P.H. Commissioner Dennis P. Whalen

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, HealthNow New York Inc. requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition.

More information

MAKING THE MOST OF YOUR PRESCRIPTION BENEFIT PROGRAM IN 2015

MAKING THE MOST OF YOUR PRESCRIPTION BENEFIT PROGRAM IN 2015 MAKING THE MOST OF YOUR PRESCRIPTION BENEFIT PROGRAM IN 2015 Your health and well-being is important to Houston Methodist and CVS/caremark. Keeping healthy includes having prescription care that is convenient

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Step Therapy Individual and Family Plan Table of Contents Coverage Policy... 1 General Background... 5 References... 5 Effective Date... 3/15/2018 Next Review

More information

Uniform Formulary Decisions 9 January 2014

Uniform Formulary Decisions 9 January 2014 Beneficiary Advisory Panel Handout Uniform Formulary Decisions 9 January 2014 Purpose: The purpose of this handout is to provide the BAP members with a reference document for the clinical effective presentation

More information

Medications Requiring Prior Authorization for Medical Necessity

Medications Requiring Prior Authorization for Medical Necessity Medications Requiring Prior Medical Necessity January 2016 Below is a list of medicines by drug class that will not be covered without a prior authorization for medical necessity. If you continue using

More information

Medications Requiring Prior Authorization for Medical Necessity

Medications Requiring Prior Authorization for Medical Necessity Medications Requiring Prior Medical Necessity January 2016 Below is a list of medicines by drug class that will not be covered without a prior authorization for medical necessity, effective January 1,

More information

STATE OF NEW YORK DEPARTMENT OF HEALTH

STATE OF NEW YORK DEPARTMENT OF HEALTH STATE OF NEW YORK DEPARTMENT OF HEALTH Corning Tower The Governor Nelson A. Rockefeller Empire State Plaza Albany, New York 12237 Antonia C. Novello, M.D., M.P.H., Dr.P.H. Commissioner Dennis P. Whalen

More information

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin Self-Administered Drug Exclusion List R2 This article from Medicare A News, Issue 2106 dated January 23, 2013 and Medicare B News, Issue 283 dated January 23, 2013 is being revised to add Acthar ACTH gel

More information

Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit

Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit Medicare Part D 2012 Formulary s Service To Senior and Total Fit Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,

More information

ASEBP and ARTA TARP Drugs and Reference Price by Categories

ASEBP and ARTA TARP Drugs and Reference Price by Categories ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201056 NOVEMBER 30, 2010 Changes to the Preferred Drug List Changes to the Preferred Drug List (PDL) were made at the November 19, 2010, Drug Utilization

More information

2019 Step Therapy (ST) Criteria

2019 Step Therapy (ST) Criteria 2019 Step Therapy (ST) Criteria Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a

More information

SmithRx Standard Formulary Step Therapy List

SmithRx Standard Formulary Step Therapy List SmithRx Standard Formulary Step Therapy List Revised: January 27, 2017 The following medications require prior use of at least one other medication for coverage. Please note that any plan-specific customizations

More information

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires

More information

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 25 March 2010

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 25 March 2010 Beneficiary Advisory Panel Handout Uniform Formulary Decisions 25 March 2010 PURPOSE: The purpose of this handout is to provide BAP Committee members with a reference document for the relative clinical

More information

THE ART OF DRUG SYNTHESIS

THE ART OF DRUG SYNTHESIS THE ART OF DRUG SYNTHESIS Edited by Douglas S. Johnson Jie Jack Li Pfizer Global Research and Development WILEY-INTERSCIENCE A JOHN WILEY & SONS, INC., PUBLICATION Foreword Preface Contributors xi xiii

More information

Step Therapy Criteria

Step Therapy Criteria ALPHA BLOCKERS CARDURA, CARDURA XL, FLOMAX, RAPAFLO, UROXATRAL Step 1 Drug(s): alfuzosin Er, doxazosin, tamsulosin, terazosin. Step 2 Drug(s): Cardura, Cardura XL, Flomax, Rapaflo, UroXatral. ANTIDEPRESSANTS

More information

MDwise Self-Administered Codes for Medical

MDwise Self-Administered Codes for Medical The following codes are associated with medications that can be self-administered by the patient or a caregiver. As a result, MDwise will transfer coverage of these self-administered medications exclusively

More information

DRUG CLASSIFICATION. Prevention of Cardiovascular Disease

DRUG CLASSIFICATION. Prevention of Cardiovascular Disease Generic Preventive Care/ Safe Harbor Drug Program List Preventive care/safe harbor drugs are drugs that can help keep you from developing a health condition or related complications of a health condition.

More information

2013 Quantity Level Limits (QLL) Criteria

2013 Quantity Level Limits (QLL) Criteria Certain drugs covered through your EmblemHealth Medicare PDP Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food and Drug Administration and manufacturer

More information

Admission History 10/15/14

Admission History 10/15/14 NURSING DOCUMENTATION OPTIMIZATION Admission History 10/15/14 Admission Assessments have been optimized and renamed as Admission Information... The forms are customized for Pre-Surgical/Procedural and

More information

Performance Drug List Change Detail Report Effective (Standard Drug List Reflects Exclusions)

Performance Drug List Change Detail Report Effective (Standard Drug List Reflects Exclusions) This report highlights all changes (additions and deletions) to the CVS Caremark Performance Drug List. ADDITIONS: Brand Agents: Betaseron (interferon beta-1b) Central Nervous System/ Multiple Sclerosis

More information

Drugs That Have Quantitiy Limits (QL)

Drugs That Have Quantitiy Limits (QL) Drugs That Have Quantitiy Limits (QL) There are Quantity Limits set by your UA Medicare Group Part D Prescription Drug Plan for the drugs listed below. The UA Medicare Group Part D Prescription Drug Plan

More information

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication. ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE

More information

Pharmacy Updates Summary

Pharmacy Updates Summary All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 10/28/2014 Effective date: 11/15/2014 Therapeutic Classes reviewed: Pulmonary arterial hypertension

More information

Value-Based Drug List for ABCs of Diabetes

Value-Based Drug List for ABCs of Diabetes Effective January 1, 2019 Value-Based Drug List for ABCs of Diabetes PCPS provides a Value-Based Benefit Design (VBD) to qualified participants in the ABCs of Diabetes. This means you will have lower out-of-pocket

More information

Before a Step 2 medication is covered You get a prescription

Before a Step 2 medication is covered You get a prescription Step Therapy Most medical conditions have multiple medication options. Although their clinical effectiveness may be similar, prices can vary widely. With the Step Therapy program, you get the treatment

More information

Drug Quantity Limits Quantity limits (QL) on medications are established to maximize the dosing regimen and decrease cost

Drug Quantity Limits Quantity limits (QL) on medications are established to maximize the dosing regimen and decrease cost Drug Quantity Limits- 2011 Quantity limits (QL) on medications are established to maximize the dosing regimen and decrease cost QLs are commonly placed on once daily drugs available in multiple strengths.

More information

Deaths Hospitalizations Company. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Janssen Pharmaceuticals

Deaths Hospitalizations Company. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Janssen Pharmaceuticals Takeaways: Diabetes Drug Investigation From: BSardi@aol.com Sent: Mon, Dec 22, 2014 at 10:51 am To: Cc: gemcap2@reagan.com martie.whittekin@verizon.net, katjames008@gmail.com clip_image002.jpg (64.5 KB)

More information

Quantity limits on medications are established to maximize the dosing regimen and decrease cost.

Quantity limits on medications are established to maximize the dosing regimen and decrease cost. Drug Quantity Limits 2011 Quantity limits on medications are established to maximize the dosing regimen and decrease cost. Quantity limits are commonly placed on once daily drugs available in multiple

More information

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC) INFECTIOUS DISEASE ACTIMMUNE INTERFERON GAMMA 1B J9216 ADVATE RAHF PFM ONCOLOGY ORAL AFINITOR EVEROLIMUS J7527 INFECTIOUS DISEASE ALFERON N INTERFERON ALFA N3 J9215 ALPHANATE VWF J7186 ALPHANINE SD J7193

More information

Medications for Type 2 Diabetes CDE Exam Preparation

Medications for Type 2 Diabetes CDE Exam Preparation Medications for Type 2 Diabetes CDE Exam Preparation Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Agenda Medication

More information

Generic Preventive Care/ Safe Harbor Drug Program List

Generic Preventive Care/ Safe Harbor Drug Program List Preventive care/safe harbor drugs are drugs that can help keep you from developing a health condition or related complications of a health condition. The Generic Preventive Care/Safe Harbor Drug Program

More information

MTF Quarterly Webcast December 9, 2010

MTF Quarterly Webcast December 9, 2010 TMA Fort Sam Houston, TX MTF Quarterly Webcast December 9, 2010 LTC Stacia Spridgen Director, 1 Introduction Greetings from the PEC Purpose of the Quarterly MTF Webcast DCO Ground Rules Type questions

More information

Step Therapy Group Algorithm Steps

Step Therapy Group Algorithm Steps Step Therapy Group Algorithm Steps ACTONEL AMITIZA ANTICONVULSANT ANTIDEPRESSION Previous trial on alendronate Step 1: ALENDRONATE SODIUM Step 2: RISEDRONATE SODIUM, RISEDRONATE SODIUM DR Previous trial

More information

Drug Target Maximum Quantity Internal

Drug Target Maximum Quantity Internal To help make the use of prescription drugs safer and more affordable, our plan is now using a Drug Quantity Management program. That is, for certain medications, you can receive an amount to last you a

More information

2014 Quantity Limits (QL) Criteria

2014 Quantity Limits (QL) Criteria 2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food

More information

2013 Quantity Level Limits (QLL) Criteria

2013 Quantity Level Limits (QLL) Criteria Certain drugs covered through your EmblemHealth Medicare PDP Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food and Drug Administration and manufacturer

More information

Step Therapy Approval Criteria

Step Therapy Approval Criteria Effective Date: 01/01/2019 This document contains for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab) 5. Imitrex Injection vial

More information

National Preferred Formulary Quantity Limits Drug List Helpful Tip: To search for a specific drug, use the find feature (Ctrl + F)

National Preferred Formulary Quantity Limits Drug List Helpful Tip: To search for a specific drug, use the find feature (Ctrl + F) Page 1 of 6 Allergies Anaphylaxis Antifungal Anti-infective Anti-infective - Specialty Anti-Influenza Asthma - Specialty Asthma/COPD National Preferred Formulary Quantity Limits Drug List Helpful Tip:

More information

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INTERIM MEETING

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INTERIM MEETING DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INTERIM MEETING Addendum December 17, 2013 I. UNIFORM FORMULARY (UF) DRUG CLASS REVIEWS A. Anti-Lipidemic-ls (LIP-ls) Background-New

More information

CONTACT POLPHARMA GROUP POLPHARMA B2B

CONTACT POLPHARMA GROUP POLPHARMA B2B DOSSIER FDFLIST Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM 1. Esomeprazole sodium or injection 40 mg Nexium / AstraZeneca Antiulcerant 2. Omeprazole

More information

Victoza (Liraglutide) Solution for Injection

Victoza (Liraglutide) Solution for Injection Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

II. UNIFORM FORMULARY CLASS REVIEWS Phosphodiesterase Type-5 (PDE-5) INHIBITORS FOR ERECTILE DYSFUNCTION (ED) P&T Comments

II. UNIFORM FORMULARY CLASS REVIEWS Phosphodiesterase Type-5 (PDE-5) INHIBITORS FOR ERECTILE DYSFUNCTION (ED) P&T Comments DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. Uniform Formulary Review Process Under 10 U.S.C. 1074g, as implemented by 32

More information

These medications will require preauthorization (PA) for HMSA Medicare Part D members.

These medications will require preauthorization (PA) for HMSA Medicare Part D members. Medicare Part D November 2014 CHANGES TO HMSA S MEDICARE FORMULARY As part of HMSA s ongoing efforts to provide our members a sustainable and affordable health plan option, it s necessary to make adjustments

More information

Drug Regimen Optimization

Drug Regimen Optimization Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Excluding Valsartan / Ramipril Prior authorization criteria logic: a description

More information

Drug / Pregnancy Conflicts Excessive Daily Doses Ingredient Duplication Insufficient Daily Doses

Drug / Pregnancy Conflicts Excessive Daily Doses Ingredient Duplication Insufficient Daily Doses Drug Utilization Review (DUR) ations (QL), Age, Gender Edits The Health Net DUR program evaluates a prescription when the pharmacy provider electronically submits the prescription. As the prescription

More information

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 U.S.C. 1074g, as implemented by 32

More information

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 723 February 2018 Pan-Canadian Select Molecule Price Initiative for Generic Drugs Alberta Drug Benefit List prices

More information

ANTIDEPRESSANTS - BUPROPION

ANTIDEPRESSANTS - BUPROPION Step Therapy Paramount Medicare Formulary 2012 Formulary ID 12112, Version 22. CMS Approved 10-23-2012. ANTIDEPRESSANTS - BUPROPION Aplenzin may be given. Step 1 Drug(s): Budeprion Sr, Budeprion Xl, Bupropion

More information

Prescription Drug Benefit Rider

Prescription Drug Benefit Rider Prescription Drug Benefit Rider Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your

More information

TECHNICAL APPENDIX: A PERSPECTIVE ON PRESCRIPTION DRUG COPAYMENT COUPONS

TECHNICAL APPENDIX: A PERSPECTIVE ON PRESCRIPTION DRUG COPAYMENT COUPONS TECHNICAL APPENDIX: A PERSPECTIVE ON PRESCRIPTION DRUG COPAYMENT COUPONS METHODS FOR DETERMINING COPAY COUPON STATUS The copay coupon information comes from www.internetdrugcoupons.com (IDC). These data

More information

Drug Regimen Optimization

Drug Regimen Optimization Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Excluding Valsartan / Ramipril Prior authorization criteria logic: a description

More information

AGGRENOX. Products Affected. Details. GRP B2 Last Updated: 09/01/2018. Aggrenox

AGGRENOX. Products Affected. Details. GRP B2 Last Updated: 09/01/2018. Aggrenox GRP B2 Last Updated: 09/01/2018 AGGRENOX Aggrenox A documented trial of one month of formulary generic aspirin/dipyridamole capsules. NR_0009_3742 09/2014 Formulary ID: 18066: version 15 1 ANTICONVULSANTS

More information

CHICAGO REGIONAL COUNCIL OF CARPENTERS WELFARE FUND RETIREE PRESCRIPTION DRUG BENEFITS October 2013

CHICAGO REGIONAL COUNCIL OF CARPENTERS WELFARE FUND RETIREE PRESCRIPTION DRUG BENEFITS October 2013 CHICAGO REGIONAL COUNCIL OF CARPENTERS WELFARE FUND RETIREE PRESCRIPTION DRUG BENEFITS October 2013 How to Use the Prescription Drug Program The Chicago Regional Council of Carpenters Welfare Fund has

More information

PharmaSuitables October Rich Price, MD Zach Kareus, Pharm.D. Steve Nolan, Pharm.D.

PharmaSuitables October Rich Price, MD Zach Kareus, Pharm.D. Steve Nolan, Pharm.D. PharmaSuitables October 2017 Rich Price, MD Zach Kareus, Pharm.D. Steve Nolan, Pharm.D. Disclosures Rich, Zach, and Steve work for Rocky Mountain Health Plans. We do not have any financial interest in

More information

Report Writing Specifications

Report Writing Specifications Report Writing Specifications Adverse Drug Events Primary Measures Anticoagulants, Opioids and Hypoglycemic Agents Washington State Hospital Association 2017 Contents Acknowledgements... 2 Terms Used in

More information

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative

More information

Prescription benefit updates Large group

Prescription benefit updates Large group Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save

More information

Preferred Drug List (Formulary) CareFirst BlueCross BlueShield

Preferred Drug List (Formulary) CareFirst BlueCross BlueShield Prescription drugs can account for a large percentage of your health care costs. By using the (CareFirst) preferred drug list, also called a formulary, you can discuss with your physician and your pharmacist

More information

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code 1074g, as implemented

More information

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate

More information

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR S/N ME OF MEDICATIONS BRANDED/GENERIC DRUG CLASS * UNIT PRICE RANGE (SGD$) 1 ACEBUTOLOL HCL 100MG CAPSULE SECTRAL BETA BLOCKERS 0.50 2 ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS 0.33 3 ALISKIREN

More information

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country

More information

Additional Standard Generics HSA Preventive Drug List Effective January 1, 2019

Additional Standard Generics HSA Preventive Drug List Effective January 1, 2019 Additional Standard Generics HSA Preventive Drug List Effective January 1, 2019 Employers can elect to include an additional generic HSA Preventive Drug coverage feature with your prescription benefit

More information